Ocrelizumab: A Deep Dive into IDC-2403's Mechanism Ocrelizumab, initially investigated as IDC-2403, demonstrates a specific pathway of action targeting B cells, key in the progression of various sclerosis https://jasonbvzs742139.wikiexpression.com/user